BE828183A - Nouveau compose antimicrobien et procede pour le produire - Google Patents

Nouveau compose antimicrobien et procede pour le produire

Info

Publication number
BE828183A
BE828183A BE155612A BE155612A BE828183A BE 828183 A BE828183 A BE 828183A BE 155612 A BE155612 A BE 155612A BE 155612 A BE155612 A BE 155612A BE 828183 A BE828183 A BE 828183A
Authority
BE
Belgium
Prior art keywords
producing
antimicrobial compound
new antimicrobial
new
compound
Prior art date
Application number
BE155612A
Other languages
English (en)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of BE828183A publication Critical patent/BE828183A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • C12P19/40—Nucleosides having a condensed ring system containing a six-membered ring having two nitrogen atoms in the same ring, e.g. purine nucleosides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/38—Nucleosides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/8215—Microorganisms
    • Y10S435/822—Microorganisms using bacteria or actinomycetales
    • Y10S435/886—Streptomyces
    • Y10S435/888—Streptomyces antibioticus

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
BE155612A 1974-04-22 1975-04-21 Nouveau compose antimicrobien et procede pour le produire BE828183A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US462826A US3923785A (en) 1974-04-22 1974-04-22 (R)-3-(2-deoxy-{62 -D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo{8 4,5-d{9 {8 1,3{9 diazepin-8-ol

Publications (1)

Publication Number Publication Date
BE828183A true BE828183A (fr) 1975-08-18

Family

ID=23837909

Family Applications (1)

Application Number Title Priority Date Filing Date
BE155612A BE828183A (fr) 1974-04-22 1975-04-21 Nouveau compose antimicrobien et procede pour le produire

Country Status (8)

Country Link
US (1) US3923785A (fr)
JP (1) JPS5848160B2 (fr)
BE (1) BE828183A (fr)
CA (1) CA1042376A (fr)
DE (1) DE2517596C2 (fr)
FR (1) FR2311552A1 (fr)
GB (1) GB1481927A (fr)
NL (1) NL186868C (fr)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60992B2 (ja) * 1977-03-15 1985-01-11 財団法人微生物化学研究会 コホルマイシンおよび関連物質の分離法
US4117229A (en) * 1977-10-11 1978-09-26 Warner-Lambert Company 2-amino-1-(5-amino-1h-imidazol-4-yl)ethanone and method of preparation
US4195176A (en) * 1977-10-11 1980-03-25 Warner-Lambert Company Imidazole compounds, methods for their production and conversion of said compounds into (R)-3-(2-deoxy-β-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazol[4,5-d][1,3]diazepin-8-ol
US4163839A (en) * 1977-12-09 1979-08-07 Zaidan Hojin Biselbutsu Kagaku Kenkyu Kai Isocoformycin and a process for the production thereof
US4935505A (en) * 1983-05-03 1990-06-19 Townsend Leroy B Novel azolo [1,3] diazepine-5-ol compounds and their uses
ATE34176T1 (de) * 1984-03-16 1988-05-15 Warner Lambert Co 2'-chloropentostatin, eine diese verbindung enthaltende pharmazeutische zusammensetzung und ein mikroorganismus zur herstellung dieser verbindung.
US4713372A (en) * 1984-03-16 1987-12-15 Warner-Lambert Company 2-chloropentostatin compound having adenosine diaminase inhibitory activity
AU5668886A (en) * 1986-03-27 1987-10-20 Harry Edward Gruber A method of increasing adenosine excretion
ES2094919T3 (es) * 1991-07-31 1997-02-01 Warner Lambert Co Proceso para purificar pentostatina.
US5773607A (en) * 1991-11-14 1998-06-30 Zaidan Hojin Biseibutsu Kagaku Kenkyu Kai Processes for preparing 2'-deoxy-2'-fluorocoformycin and stereoisomers thereof
JPH09241294A (ja) * 1996-03-07 1997-09-16 Microbial Chem Res Found ２′−デオキシ−２′−ハロコホルマイシン又はその立体異性体の製造法
US6174873B1 (en) 1998-11-04 2001-01-16 Supergen, Inc. Oral administration of adenosine analogs
US20020086835A1 (en) * 2000-05-22 2002-07-04 Law William R. Use of adenosine deaminase inhibitors to treat systemic inflammatory response syndrome
US7829084B2 (en) 2001-01-17 2010-11-09 Trubion Pharmaceuticals, Inc. Binding constructs and methods for use thereof
WO2009042064A2 (fr) 2007-09-21 2009-04-02 Nektar Therapeutics Al, Corporation Conjugués nucléoside phosphate oligomères
US8173621B2 (en) 2008-06-11 2012-05-08 Gilead Pharmasset Llc Nucleoside cyclicphosphates
PA8855601A1 (es) 2008-12-23 2010-07-27 Forformidatos de nucleósidos
AU2009329872B2 (en) * 2008-12-23 2016-07-07 Gilead Pharmasset Llc Synthesis of purine nucleosides
NZ593649A (en) * 2008-12-23 2013-11-29 Gilead Pharmasset Llc Nucleoside analogs
CN101792722B (zh) * 2009-02-04 2013-04-10 杭州华东医药集团生物工程研究所有限公司 一种链霉菌及其应用
CN101798330A (zh) * 2009-02-06 2010-08-11 杭州华东医药集团生物工程研究所有限公司 一种喷司他丁的提取纯化方法
US20100261666A1 (en) * 2009-04-14 2010-10-14 The Board Of Trustees Of The University Of Illinois Compositions and methods for the treatment of myocardial dysfunction associated with sirs or sepsis
SG184324A1 (en) 2010-03-31 2012-11-29 Gilead Pharmasset Llc Nucleoside phosphoramidates
CN102234673B (zh) * 2010-04-29 2014-03-26 上海医药工业研究院 抗生链霉菌发酵生产喷司他丁的发酵培养基以及发酵方法
CN102453065B (zh) * 2010-10-29 2014-12-17 上海医药工业研究院 一种去除喷司他丁发酵液中杂质的方法
WO2016105499A1 (fr) 2014-12-23 2016-06-30 Intellectual Property Associates, Llc Méthodes et formulations pour l'administration transdermique
EP3681479B1 (fr) 2017-09-15 2024-01-31 Dyve Biosciences, Inc. Bicarbonate de sodium pour utilisation dans le traitement de la goutte et de troubles associés
CN108586556B (zh) * 2018-01-17 2021-04-20 浙江海正药业股份有限公司 一种喷司他丁的晶型及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3616208A (en) * 1967-09-29 1971-10-26 Parke Davis & Co Fermentation process for 9-(beta-d-arabinofuranosyl)adenine
BE756704A (fr) * 1969-09-26 1971-03-01 Parke Davis & Co Procede de production du 5'-phosphate de 9-(beta-d- arabinofuranosyl) adenine et de ses sels
US3792036A (en) * 1970-01-07 1974-02-12 Ciba Geigy Corp Pteridine-glycosides

Also Published As

Publication number Publication date
FR2311552B1 (fr) 1979-06-08
NL186868B (nl) 1990-10-16
JPS5848160B2 (ja) 1983-10-26
NL7504710A (nl) 1975-10-24
GB1481927A (en) 1977-08-03
DE2517596A1 (de) 1975-10-30
CA1042376A (fr) 1978-11-14
JPS50145590A (fr) 1975-11-21
US3923785A (en) 1975-12-02
NL186868C (nl) 1991-03-18
DE2517596C2 (de) 1987-05-14
FR2311552A1 (fr) 1976-12-17

Similar Documents

Publication Publication Date Title
BE828183A (fr) Nouveau compose antimicrobien et procede pour le produire
RO70907A (fr) Procede pour obtenir n-phosphonomethyleglycine
BE831146A (fr) Procede pour produire des microcapsules polymeriques
RO68142A (fr) Procede pour la preparation des 4-phenylpyperidines
FR2274990A1 (fr) Procede de fabrication de cassettes pour magnetophones et cassettes obtenues par ce procede
YU143775A (en) Process for producing antibacterial agents
RO65454A (fr) Procede pour la preparation des calcones substituees
FR2275857A1 (fr) Monochromateur et procede pour la former
FR2279868A1 (fr) Procede pour la production d'un file d'effet
RO72434A (fr) Procede pour la preparation des thiolcarbamates
RO72483A (fr) Procede continuu pour la fabrication du 2-ethylexanol
YU126982A (en) Process for producing antibacterial agents
RO63021A (fr) Procede pour la preparation des 3-fluorcephalosporines
FR2285725A1 (fr) Revetement supraconducteur et procede pour le former
BE819877A (fr) Saucisse et procede pour sa fabrication
RO64281A (fr) Procede pour la preparation des 6-methyle-8-methylergolines substituees
RO68749A (fr) Procede pour la preparation des 2-amidoimidazoles
BE814741A (fr) Nouveau compose hypolipemique et son procede de preparation
BE825289A (fr) Nouveau 1-phenoxy-3-isopropylamino-2-propanol et procede pour sa preparation.
FR2322133A1 (fr) Procede pour produire des acyl-taurides
BE804615A (fr) Nouveau procede de reduction
BE810322A (fr) Nouveau procede de decoupe
BE824730A (fr) Procede pour la preparation de cyclopentandiones
FR2282276A1 (fr) S-inosylcysteine et procede pour sa preparation
RO76829A (fr) Procede pour la cristallisation du fructose

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: DAVIS & CY

Effective date: 19950421

Owner name: PARKE

Effective date: 19950421